# Feasibility of Measuring Immune Resp, Activation in Foreskin/Mucosa in HIV-, Uncircumcised High-HIV-risk MSM, Lima Peru

> **NCT02630082** · NA · COMPLETED · sponsor: **National Institute of Allergy and Infectious Diseases (NIAID)** · enrollment: 29 (actual)

## Conditions studied

- HIV Infections
- Acquired Immunodeficiency Syndrome
- Lentivirus Infections
- Retroviridae Infections
- RNA Virus Infections
- Virus Diseases
- Sexually Transmitted Diseases, Viral
- Sexually Transmitted Diseases
- Immunologic Deficiency Syndromes
- Immune System Diseases
- Slow Virus Diseases

## Interventions

- **PROCEDURE:** Circumcision
- **PROCEDURE:** Flexible sigmoidoscopy

## Key facts

- **NCT ID:** NCT02630082
- **Lead sponsor:** National Institute of Allergy and Infectious Diseases (NIAID)
- **Sponsor class:** NIH
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-04
- **Primary completion:** 2013-03
- **Final completion:** 2013-03
- **Target enrollment:** 29 (ACTUAL)
- **Last updated:** 2015-12-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02630082

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02630082, "Feasibility of Measuring Immune Resp, Activation in Foreskin/Mucosa in HIV-, Uncircumcised High-HIV-risk MSM, Lima Peru". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT02630082. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
